<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Probi Ltd</title>
	<link>http://probi.se/en</link>
	<description></description>
	<lastBuildDate>Wed, 09 May 2012 14:24:57 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>Probi and Vifor Pharma sign agreement to launch Probi Digestis® and Probi Defendum® in Switzerland</title>
		<description><![CDATA[2012-05-08 Probi and Vifor Pharma sign agreement to launch Probi Digestis® and Probi Defendum® in Switzerland Probi has signed a distribution and co-marketing agreement with Vifor Pharma, a company of the Galenica Group, to launch Probi’s gut and immune health products on the Swiss pharmacy and drugstore market. The range will be sold under the [...]]]></description>
		<link>http://probi.se/en/2012/05/08/probi-and-vifor-pharma-sign-agreement-to-launch-probi-digestis%c2%ae-and-probi-defendum%c2%ae-in-switzerland/</link>
			</item>
	<item>
		<title>Interim Report January &#8211; March 2012</title>
		<description><![CDATA[2012-04-26 28% growth in first quarter Click here to read the release]]></description>
		<link>http://probi.se/en/2012/04/26/interim-report-january-march-2012/</link>
			</item>
	<item>
		<title>Probi and Heinz to launch the first probiotic juice in Australia</title>
		<description><![CDATA[2012-04-19 Probi and Heinz to launch the first probiotic juice in Australia Heinz Australia will launch Golden Circle Healthy Life™ Probiotic Juice in May 2012. The product range is based on Probi´s unique immune supporting platform Probi Defendum®and will create a new category of probiotic juices on the Australian market. Read the full release here]]></description>
		<link>http://probi.se/en/2012/04/19/probi-and-heinz-to-launch-the-first-probiotic-juice-in-australia/</link>
			</item>
	<item>
		<title>Probi signs agreement with a probiotic leader in India</title>
		<description><![CDATA[2012-03-21 Probi signs agreement with a probiotic leader in India Probi has signed a distribution agreement with USV Limited, a leading Indian Pharmaceutical company. USV will launch Vibact IBS based on the probiotic formulation Probi Digestis, in Q4 2012 in the growing Indian market. The agreement reinforces and strengthens Probi&#8217;s existing presence in the large [...]]]></description>
		<link>http://probi.se/en/2012/03/21/probi-signs-agreement-with-a-probiotic-leader-in-india/</link>
			</item>
	<item>
		<title>New Vice President Research &amp; Development</title>
		<description><![CDATA[2012-02-29 Gun-Britt Fransson new Vice President Research &#38; Development at Probi Probi is expanding its management team through the appointment of Gun-Britt Fransson as Vice President Research &#38; Development. Gun-Britt Fransson, who assumed her new position during February 2012, has held senior positions in the biotechnology and food industries for the past 20 years, most [...]]]></description>
		<link>http://probi.se/en/2012/02/29/new-vice-president-research-development/</link>
			</item>
	<item>
		<title>Preliminary Annual Report 2011</title>
		<description><![CDATA[2012-01-25 Continued high growth driven by ProbiMage and ProbiFrisk Preliminary Annual Report 2011]]></description>
		<link>http://probi.se/en/2012/01/25/preliminary-annual-report-2011/</link>
			</item>
	<item>
		<title>Probi signs co-development agreement</title>
		<description><![CDATA[2011-11-03 Probi signs co-development agreement with leading global food company Probi has entered into a co-development agreement with a leading global food company focusing on joint clinical development of Probi’s immune health platform ProbiDefendumTM. The objective of the collaboration is to further strengthen the clinical platform of ProbiDefendumTM in preparation of the application for a [...]]]></description>
		<link>http://probi.se/en/2011/11/03/probi-signs-co-development-agreement/</link>
			</item>
	<item>
		<title>Interim Report January &#8211; September 2011</title>
		<description><![CDATA[2011-10-19 Continued high growth and US breakthrough for dietary supplements Read the full release here &#160;]]></description>
		<link>http://probi.se/en/2011/10/19/interim-report-january-september-2011/</link>
			</item>
	<item>
		<title>Breakthrough for Probi in the U.S.</title>
		<description><![CDATA[2011-08-25 Breakthrough for Probi in U.S. mass retail and mass drug VMS market Probi has signed one of its most signficant dietary supplement agreements to date with Pharmavite, a leader in the US vitamin, minerals and supplement market (VMS). Pharmavite will launch Probi’s gut health capsules containing Lp299v™ at the beginning of 2012 under the Nature [...]]]></description>
		<link>http://probi.se/en/2011/08/25/breakthrough-for-probi-in-the-u-s/</link>
			</item>
	<item>
		<title>Probi repurchases treasury shares</title>
		<description><![CDATA[2011-08-15 The Board of Directos of Probi AB has resolved to utilise the authorisation granted by the Annual General Meeting of Shareholders to repurchase shares in the company. Read the full release here]]></description>
		<link>http://probi.se/en/2011/08/15/probi-repurchases-treasury-shares/</link>
			</item>
</channel>
</rss>

